Compartir, , Google Plus, Pinterest,

Posted in:

IMI 2. Call 15 (H2020-JTI-IMI2-2018-15-Two-Stage)

Se compone de 8 topics en distintas áreas de la biomedicina:

◾Topic 1: Integrated research platforms enabling patient-centric drug development.
◾Topic 2: Blockchain Enabled Healthcare.
◾Topic 3: Microenvironment imposed signatures in tissue and liquid biopsies in immune-mediated diseases.
◾Topic 4: Emerging translational safety technologies and tools for interrogating human immuno-biology.
◾Topic 5: Development and validation of translational platforms in support of synaptopathy drug discovery.
◾Topic 6: Digital endpoints in neurodegenerative and immune-mediated diseases.
◾Topic 7: AMR Accelerator programme Pillar A: Capability Building Network to accelerate and validate scientific discoveries.
◾Topic 8: AMR Accelerator programme Pillar B: Tuberculosis drug development network to accelerate and validate scientific discoveries and advance the R&D pipeline of new and innovative agents to address the global tuberculosis epidemic.

Consta de 2 etapas, siendo el cierre de la primera etapa el 24 de octubre 2018. Los proyectos que sean invitados a pasar a la segunda etapa tendrán la fecha de cierre el 15 de mayo 2019. El presupuesto global para esta convocatoria es de 214,8 M€.

Más información